BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31557540)

  • 1. High-throughput phenotyping of heteromeric human ether-à-go-go-related gene potassium channel variants can discriminate pathogenic from rare benign variants.
    Ng CA; Perry MD; Liang W; Smith NJ; Foo B; Shrier A; Lukacs GL; Hill AP; Vandenberg JI
    Heart Rhythm; 2020 Mar; 17(3):492-500. PubMed ID: 31557540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance.
    Copier JS; Bootsma M; Ng CA; Wilde AAM; Bertels RA; Bikker H; Christiaans I; van der Crabben SN; Hol JA; Koopmann TT; Knijnenburg J; Lommerse AAJ; van der Smagt JJ; Bezzina CR; Vandenberg JI; Verkerk AO; Barge-Schaapveld DQCM; Lodder EM
    Hum Mol Genet; 2023 Mar; 32(7):1072-1082. PubMed ID: 36269083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A calibrated functional patch-clamp assay to enhance clinical variant interpretation in KCNH2-related long QT syndrome.
    Jiang C; Richardson E; Farr J; Hill AP; Ullah R; Kroncke BM; Harrison SM; Thomson KL; Ingles J; Vandenberg JI; Ng CA
    Am J Hum Genet; 2022 Jul; 109(7):1199-1207. PubMed ID: 35688147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
    Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
    Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous
    Ng CA; Farr J; Young P; Windley MJ; Perry MD; Hill AP; Vandenberg JI
    Biol Methods Protoc; 2021; 6(1):bpab003. PubMed ID: 33884304
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel missense mutation causing a G487R substitution in the S2-S3 loop of human ether-à-go-go-related gene channel.
    Kinoshita K; Yamaguchi Y; Nishide K; Kimoto K; Nonobe Y; Fujita A; Asano K; Tabata T; Mori H; Inoue H; Hata Y; Fukurotani K; Nishida N
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1246-53. PubMed ID: 22764740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
    Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency.
    Paulussen AD; Raes A; Jongbloed RJ; Gilissen RA; Wilde AA; Snyders DJ; Smeets HJ; Aerssens J
    Cardiovasc Res; 2005 Aug; 67(3):467-75. PubMed ID: 15958262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome.
    Verkerk AO; Wilders R; Schulze-Bahr E; Beekman L; Bhuiyan ZA; Bertrand J; Eckardt L; Lin D; Borggrefe M; Breithardt G; Mannens MM; Tan HL; Wilde AA; Bezzina CR
    Cardiovasc Res; 2005 Dec; 68(3):441-53. PubMed ID: 16043162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of the genome aggregation database, in silico tools, and heterologous expression patch-clamp studies to identify and demote previously published type 2 long QT syndrome: Causative variants from pathogenic to likely benign.
    Mattivi CL; Ye D; Tester DJ; Clemens DJ; Zhou W; Giudicessi JR; Ackerman MJ
    Heart Rhythm; 2020 Feb; 17(2):315-323. PubMed ID: 31493592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Invalidation of Putative Sudden Infant Death Syndrome-Associated Variants in the
    Smith JL; Tester DJ; Hall AR; Burgess DE; Hsu CC; Elayi SC; Anderson CL; January CT; Luo JZ; Hartzel DN; Mirshahi UL; Murray MF; Mirshahi T; Ackerman MJ; Delisle BP
    Circ Arrhythm Electrophysiol; 2018 May; 11(5):e005859. PubMed ID: 29752375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.
    Hisajima N; Hata Y; Kinoshita K; Fukushima T; Nishida N; Kano M; Tabata T
    Biol Pharm Bull; 2015; 38(5):781-4. PubMed ID: 25947924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic Complexity in Long QT Syndrome: A Family-Case Study.
    Zullo A; Frisso G; Detta N; Sarubbi B; Romeo E; Cordella A; Vanoye CG; Calabrò R; George AL; Salvatore F
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of loss of Kv11.1 K+ current in mutant T421M-Kv11.1-expressing rat ventricular myocytes: interaction of trafficking and gating.
    Balijepalli SY; Lim E; Concannon SP; Chew CL; Holzem KE; Tester DJ; Ackerman MJ; Delisle BP; Balijepalli RC; January CT
    Circulation; 2012 Dec; 126(24):2809-18. PubMed ID: 23136156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the KCNH2 gene associated with short QT syndrome.
    Sun Y; Quan XQ; Fromme S; Cox RH; Zhang P; Zhang L; Guo D; Guo J; Patel C; Kowey PR; Yan GX
    J Mol Cell Cardiol; 2011 Mar; 50(3):433-41. PubMed ID: 21130771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A massively parallel assay accurately discriminates between functionally normal and abnormal variants in a hotspot domain of KCNH2.
    Ng CA; Ullah R; Farr J; Hill AP; Kozek KA; Vanags LR; Mitchell DW; Kroncke BM; Vandenberg JI
    Am J Hum Genet; 2022 Jul; 109(7):1208-1216. PubMed ID: 35688148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel intracellular transport-refractory mutations in KCNH2 identified in patients with symptomatic long QT syndrome.
    Fukumoto D; Ding WG; Wada Y; Fujii Y; Ichikawa M; Takayama K; Fukuyama M; Kato K; Itoh H; Makiyama T; Omatsu-Kanbe M; Matsuura H; Horie M; Ohno S
    J Cardiol; 2018 Apr; 71(4):401-408. PubMed ID: 29146210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel K
    Kozek KA; Glazer AM; Ng CA; Blackwell D; Egly CL; Vanags LR; Blair M; Mitchell D; Matreyek KA; Fowler DM; Knollmann BC; Vandenberg JI; Roden DM; Kroncke BM
    Heart Rhythm; 2020 Dec; 17(12):2180-2189. PubMed ID: 32522694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined gating and trafficking defect in Kv11.1 manifests as a malignant long QT syndrome phenotype in a large Danish p.F29L founder family.
    Kanters JK; Skibsbye L; Hedley PL; Dembic M; Liang B; Hagen CM; Eschen O; Grunnet M; Christiansen M; Jespersen T
    Scand J Clin Lab Invest; 2015; 75(8):699-709. PubMed ID: 26403377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HERG-F463L potassium channels linked to long QT syndrome reduce I(Kr) current by a trafficking-deficient mechanism.
    Yang HT; Sun CF; Cui CC; Xue XL; Zhang AF; Li HB; Wang DQ; Shu J
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):822-7. PubMed ID: 19215240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.